AnaptysBio, Inc. (ANAB) vs uniQure N.V. (QURE)
- AnaptysBio, Inc. ANAB 46.61 −4.31%
- uniQure N.V. QURE 21.72 −3.55%
AnaptysBio, Inc. and uniQure N.V. are both Biotechnology companies. AnaptysBio, Inc. and uniQure N.V. are of similar size ($1.6B and $1.5B). AnaptysBio, Inc. grew revenue faster over the last twelve months: 107.7% against 30.2%. AnaptysBio, Inc. has the higher net margin (−11.5% vs −1,350.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, AnaptysBio, Inc. leads on 15 and uniQure N.V. on 2.
Valuation
Profitability
| Metric | ANAB | QURE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 92.49% | 65.16% |
| Operating margin | 17.56% | (1,071.53%) | 0.00% |
| Net margin | (11.53%) | (1,350.73%) | 0.00% |
| Free cash flow margin | 1.90% | (864.67%) | 0.00% |
| Return on equity | (114.55%) | (157.61%) | (56.36%) |
| Return on assets | (7.13%) | (32.13%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack